Future of PharmaceuticalsDec, 2019
It takes an average of 10-15 years to get a drug to market, but how will artificial intelligence make a difference in the early development stages of drugs? Our Future of Pharmaceuticals special report, published in The Times, explores how the industry is moving to be part of open, learning communities where collaboration is at the forefront. It examines why pharmaceuticals is lagging behind in exploiting technological possibilities and whether we should redefine ageing as a disease. It looks at antimicrobial resistance and what antibiotics are really worth. Also featured is an infographic analysing the global rise of generic drugs.
In many countries around the world, scepticism around generic drugs endures, in spite of the fact that they are “bioequivalent” to (chemically the same as) their branded counterparts. But this attitude seems to be shifting as much cheaper generic drugs make up an increasing share of the global market, receiving a larger proportion of drug spend and, in so doing, saving countries billions of dollars